Niemann Pick type C - PIAM farmaceutici s.p.a

Niemann Pick type C is a disease of lysosomal lipid accumulation: patients with this disease are unable to metabolise lipids (e.g. cholesterol) properly, and they tend to accumulate lipids in the liver, spleen and other organs. The prevalence in the general population is about 1/100,000. The disease is characterized by autosomal recessive transmission and can […]

Niemann-Pick Disease Concise Medical Knowledge

PIAM farmaceutici Pharma & Integrative care

Experimental treatment for Niemann-Pick disease appears safe

Treatment Options for Niemann-Pick Type C

Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson

Niemann–Pick disease - Wikipedia

What is Niemann-Pick Type C?

Niemann-Pick disease - Breda Genetics srl Breda Genetics srl

Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions - ScienceDirect

WEBINAR “Niemann-Pick Type C: Two Genes - Many Clinical Pictures - One Unifying Biomarker”

Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library